Page 16 - Trial Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This first-in-class STAMP inhibitor is approved for use in patients with chronic myeloid leukemia who have developed resistance to tyrosine kinase inhibitors.

Operations and the logistics. so as soon as we have both the fda authorization and the cdc recommendations, there will be vaccine out there, so children can start rolling up their sleeves. >> reporter: 28 million children in the u.s. would be newly eligible. pfizer's early trial data showing the vaccine, one-third the adult dose, is nearly 91% effective against symptomatic illness in young children. also reporting zero cases of myocarditis, inflammation of the heart muscle, occurring most often in young men a few weeks after the second shot. >> the younger age group had less severe side effect...

You know, i always thought this was a two-dose vaccine all along. i know the company had hoped that it could serve as a one-dose vaccine from the simple standpoint that globally, you know, it could go much faster and spread among -- and be delivered to many more people globally. so i think their intentions were good. and they actually finally came -- had phase-three trial data for the two doses in september. and it was pretty stunning. it's over 90% protection. so i wish it was messaged a little differently. you know, what i've been saying since the beginning, since january, is that the two mr...

Not really a booster. it turns out this was always a two-dose vaccine. something that we've talked about all year. you know, when we looked at the early phase one, phase-two trial data, it really needed two doses to get consistently high levels of virus neutralizing antibody for everyone. and at that point it was a really, really good vaccine. so there is a subtle difference. with the pfizer vaccine, for instance, there's clear waning, munts, and you need a booster to restore the immunity. with the j&j, the vaccine immunity is staying constant. it's just not at a high enough level. it's around...

Councilmember conditional said it would not block an extension in december. we'll talk to senator menendez about where negotiations stand. exclusive reporting from nbc news reveals the u.s. government knew back in july that thousands of haitians were preparing to head to the united states. julia ainsley will discuss the failures that contributed to the humanitarian disaster. we begin this hour with breaking news that pfizer is asking the fda to authorize its covid-19 vaccine for use in children ages 5 to 11. last month the company announced that based on trial data, their vaccine was safe an...